News
US-based HistoSonics has secured the first major insurance coverage for its histotripsy system, amid media speculation of a ...
GE HealthCare has obtained the FDA’s blessing for its latest imaging system combining SPECT and CT scanning, as well as for ...
HistoSonics is shopping for a potential buyer of its approach to destroying liver tumors with focused sound waves, according ...
Several multinational medical device makers are focusing on deepening their presence in India by expanding their local ...
GEHC Q1 results are likely to reflect strong growth in Imaging, Ultrasound, and AI, fueled by robust procedure volumes and global partnerships despite China headwinds.
The Financial Times reports today that histotripsy tech developer HistoSonics is considering a potential sale after receiving ...
Mammography innovations streamline exam workflows for patient-centered breast care GE HealthCare’s latest technologies include the Pristina Via™ mammography system, which provides effortless ...
The global MRI Systems Market, valued at US$6.15 billion in 2024, is forecasted to grow at a robust CAGR of 6.5%, reaching US$6.56 billion in ...
St. Luke’s is investing over $30M in AI-enhanced MRI tech from GE HealthCare to improve image quality, reduce scan times, and ...
17d
Zacks Investment Research on MSNHere's Why You Should Hold the GEHC Stock in Your Portfolio for NowGE HealthCare Technologies, Inc. GEHC is well-poised for growth in the coming quarters, courtesy of its continued focus on innovations. The optimism, led by strong fourth-quarter 2024 performance and ...
covering everything from advanced imaging systems and ultrasound devices to patient monitoring solutions and diagnostic agents. Headquartered in Chicago, Illinois, GE HealthCare Technologies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results